Clément Bonnet

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Genetic Diversity

Advanced Non Small Cell Lung Cancer

Squamous Cell Carcinoma

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lounes Djerroudi, Julien Masliah Planchon, Hervé J Brisse, Sophie El Zein, Sylvie Helfre, Dimitri Tzanis, Nadim Hamzaoui, Clément Bonnet, Valérie Laurence, Sylvie Bonvalot, Sarah Watson
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab. JCO precision oncology 7 (2023)
Lounes Djerroudi, Julien Masliah Planchon, Hervé J Brisse, Sophie El Zein, Sylvie Helfre, Dimitri Tzanis, Nadim Hamzaoui, Clément Bonnet, Valérie Laurence, Sylvie Bonvalot, Sarah Watson
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab. JCO precision oncology 7 (2023)
Lounes Djerroudi, Julien Masliah Planchon, Hervé J Brisse, Sophie El Zein, Sylvie Helfre, Dimitri Tzanis, Nadim Hamzaoui, Clément Bonnet, Valérie Laurence, Sylvie Bonvalot, Sarah Watson
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab. JCO precision oncology 7 (2023)
Lounes Djerroudi, Julien Masliah Planchon, Hervé J Brisse, Sophie El Zein, Sylvie Helfre, Dimitri Tzanis, Nadim Hamzaoui, Clément Bonnet, Valérie Laurence, Sylvie Bonvalot, Sarah Watson
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab. JCO precision oncology 7 (2023)